Key Takeaway: Biogen Inc. has announced an investor webcast scheduled for July 14, 2026, during the Alzheimer's Association International Conference (AAIC) in London. The live event will feature Biogen management and aims to provide insights into the company's initiatives in Alzheimer's research. This webcast underscores Biogen's ongoing engagement with the investor community.
Price reaction · baseline $208.46 (2026-07-06 close) · hit pre-market · clean, no other BIIB news in the window
day 0 close
-1.3%
Market Sentiment Analysis
POSITIVE FACTORS
Biogen is actively engaging with investors.
The event highlights Biogen's commitment to Alzheimer's research.
Hosting the webcast at a significant conference increases visibility.
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+34%
120-day peak, hindsight
Typical move
1.8%
average across 15 past catalysts
Lead asset
Alefacept
Phase 3 · Chronic Plaque Psoriasis
Full Press Release Details
Cambridge, Mass.— Biogen Inc. (Nasdaq: BIIB) today announced it will hold an investor webcast on Tuesday, July 14, 2026, from the Alzheimer's Association International Conference (AAIC) in London. The Company will host a live webcast with Biogen management at 12:00 p.m. ET.
Frequently Asked Questions
When is Biogen's investor webcast scheduled?
The investor webcast is scheduled for July 14, 2026.
Where will the webcast take place?
The webcast will take place at the Alzheimer's Association International Conference in London.